Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9117422 | Metabolism | 2005 | 8 Pages |
Abstract
Cessation of blood glucose-lowering therapy in combination with a 2-day VLCD does not lead to hyperglycemia and is associated with a reduction in basal EGP. Insulin-stimulated whole body glucose disposal did not improve, nor did insulin suppressibility of EGP and lipolysis.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Endocrinology
Authors
Ingrid M. Jazet, Hanno Pijl, Marijke Frölich, Johannes A. Romijn, A. Edo Meinders,